NASDAQ:ONTX - Onconova Therapeutics News Headlines

$2.30
-0.03 (-1.29 %)
(As of 07/19/2019 04:00 PM ET)
Today's Range
$2.30
Now: $2.30
$2.5150
50-Day Range
$2.41
MA: $3.11
$3.86
52-Week Range
$1.69
Now: $2.30
$11.17
Volume18,196 shs
Average Volume36,734 shs
Market Capitalization$13.80 million
P/E RatioN/A
Dividend YieldN/A
Beta2.69

Headlines

Onconova Therapeutics (NASDAQ ONTX) News Headlines

Source:
DateHeadline
Short Interest in Onconova Therapeutics Inc (NASDAQ:ONTX) Declines By 8.4%Short Interest in Onconova Therapeutics Inc (NASDAQ:ONTX) Declines By 8.4%
www.americanbankingnews.com - July 14 at 9:35 PM
Onconova Therapeutics Inc (NASDAQ:ONTX) Major Shareholder Sells $30,923.41 in StockOnconova Therapeutics Inc (NASDAQ:ONTX) Major Shareholder Sells $30,923.41 in Stock
www.americanbankingnews.com - July 11 at 5:18 PM
Onconova Therapeutics Inc (NASDAQ:ONTX) Short Interest UpdateOnconova Therapeutics Inc (NASDAQ:ONTX) Short Interest Update
www.americanbankingnews.com - June 27 at 6:20 PM
Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology AssociationOnconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association
finance.yahoo.com - June 10 at 11:43 AM
Onconova Therapeutics Announces Presentations at Three Upcoming ConferencesOnconova Therapeutics Announces Presentations at Three Upcoming Conferences
finance.yahoo.com - May 28 at 11:26 AM
Edited Transcript of ONTX earnings conference call or presentation 14-May-19 1:00pm GMTEdited Transcript of ONTX earnings conference call or presentation 14-May-19 1:00pm GMT
finance.yahoo.com - May 15 at 11:35 AM
Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q1 2019 Results - Earnings Call TranscriptOnconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 14 at 4:23 PM
Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial ResultsOnconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results
finance.yahoo.com - May 14 at 11:54 AM
Newtown biopharm firm could reap $50M from Chinese licensing dealNewtown biopharm firm could reap $50M from Chinese licensing deal
finance.yahoo.com - May 13 at 4:25 PM
OPTT, MARA among premarket gainersOPTT, MARA among premarket gainers
seekingalpha.com - May 13 at 11:42 AM
Onconova up 11% premarket on rigosertib deal in ChinaOnconova up 11% premarket on rigosertib deal in China
seekingalpha.com - May 13 at 11:42 AM
Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater ChinaOnconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
finance.yahoo.com - May 13 at 11:42 AM
Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2019 Financial ResultsOnconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2019 Financial Results
finance.yahoo.com - May 7 at 11:38 AM
Onconova Therapeutics to Present Update at the 2019 HCW Global Life Sciences Conference in London, April 7-9Onconova Therapeutics to Present Update at the 2019 HCW Global Life Sciences Conference in London, April 7-9
finance.yahoo.com - April 2 at 11:37 AM
Onconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q4 2018 Results - Earnings Call TranscriptOnconova Therapeutics, Inc. (ONTX) CEO Steve Fruchtman on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 27 at 12:51 PM
Edited Transcript of ONTX earnings conference call or presentation 26-Mar-19 1:00pm GMTEdited Transcript of ONTX earnings conference call or presentation 26-Mar-19 1:00pm GMT
finance.yahoo.com - March 27 at 12:51 PM
Onconova Therapeutics (ONTX) CEO, Steve Fruchtman on Q4 2018 Results - Earnings Call TranscriptOnconova Therapeutics (ONTX) CEO, Steve Fruchtman on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - March 26 at 3:59 PM
Onconova Therapeutics FY 2018 Earnings PreviewOnconova Therapeutics FY 2018 Earnings Preview
seekingalpha.com - March 26 at 12:13 PM
Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2018 Financial ResultsOnconova Therapeutics, Inc. Reports Business Highlights and Full Year 2018 Financial Results
finance.yahoo.com - March 26 at 12:13 PM
Onconova Achieves Over 75 Percent of Planned Enrollment in Pivotal Phase 3 INSPIRE Study of Rigosertib in Myelodysplastic SyndromesOnconova Achieves Over 75 Percent of Planned Enrollment in Pivotal Phase 3 INSPIRE Study of Rigosertib in Myelodysplastic Syndromes
finance.yahoo.com - March 25 at 10:08 AM
Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2018 Financial ResultsOnconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2018 Financial Results
finance.yahoo.com - March 19 at 9:52 AM
Onconova Therapeutics, Inc. Estimate MomentumOnconova Therapeutics, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 4:02 PM
Onconova Therapeutics, Inc. to Participate at the 31st Annual ROTH Conference March 17-19, 2019 in Orange County, CA - GlobeNewswireOnconova Therapeutics, Inc. to Participate at the 31st Annual ROTH Conference March 17-19, 2019 in Orange County, CA - GlobeNewswire
globenewswire.com - March 13 at 11:49 AM
Onconova Therapeutics, Inc. to Present Corporate Update at the BIO CEO & Investor Conference in New York CityOnconova Therapeutics, Inc. to Present Corporate Update at the BIO CEO & Investor Conference in New York City
finance.yahoo.com - February 4 at 8:18 AM
Advancements in the Treatment of Myelodysplastic Syndromes and RAS-Mutated Lung Cancers to be Presented by Key Opinion Leaders on Thursday, February 7, 2019, in New York CityAdvancements in the Treatment of Myelodysplastic Syndromes and RAS-Mutated Lung Cancers to be Presented by Key Opinion Leaders on Thursday, February 7, 2019, in New York City
finance.yahoo.com - January 31 at 11:08 AM
Onconova Therapeutics, Inc. to Present at the NobleCON 15th Annual Investor Conference in Fort Lauderdale, FLOnconova Therapeutics, Inc. to Present at the NobleCON 15th Annual Investor Conference in Fort Lauderdale, FL
www.nasdaq.com - January 22 at 10:49 AM
Onconova Therapeutics, Inc. to Present at the NobleCON 15th Annual Investor Conference in Fort Lauderdale, FLOnconova Therapeutics, Inc. to Present at the NobleCON 15th Annual Investor Conference in Fort Lauderdale, FL
finance.yahoo.com - January 22 at 10:49 AM
Onconova Therapeutics Promotes Dr. Steven M. Fruchtman to Chief Executive Officer - GlobeNewswireOnconova Therapeutics Promotes Dr. Steven M. Fruchtman to Chief Executive Officer - GlobeNewswire
globenewswire.com - January 17 at 3:52 PM
Onconova Therapeutics promotes Dr. Steven Fruchtman to CEOOnconova Therapeutics promotes Dr. Steven Fruchtman to CEO
seekingalpha.com - January 16 at 3:58 PM
New CEO at OnconovaNew CEO at Onconova
seekingalpha.com - January 16 at 10:58 AM
Onconova Therapeutics Promotes Dr. Steven M. Fruchtman to Chief Executive OfficerOnconova Therapeutics Promotes Dr. Steven M. Fruchtman to Chief Executive Officer
finance.yahoo.com - January 16 at 10:58 AM
Onconova Therapeutics (ONTX) Submits SPA to FDA for Phase 3 Trial of Oral Rigosertib - StreetInsider.comOnconova Therapeutics (ONTX) Submits SPA to FDA for Phase 3 Trial of Oral Rigosertib - StreetInsider.com
www.streetinsider.com - January 4 at 8:57 AM
Onconova readies late-stage study jof rigosertib combo in myelodysplastic syndromesOnconova readies late-stage study jof rigosertib combo in myelodysplastic syndromes
seekingalpha.com - January 2 at 10:05 AM
Onconova Submits Special Protocol Assessment (SPA) to FDA for Phase 3 Trial of Oral Rigosertib in Combination with Azacitidine (Vidaza®) for First-Line Myelodysplastic Syndromes (MDS)Onconova Submits Special Protocol Assessment (SPA) to FDA for Phase 3 Trial of Oral Rigosertib in Combination with Azacitidine (Vidaza®) for First-Line Myelodysplastic Syndromes (MDS)
finance.yahoo.com - January 2 at 10:05 AM
Onconova to Meet Investors and Potential Partners at China Focus and the 37th Annual J.P. Morgan Healthcare Conferences in San FranciscoOnconova to Meet Investors and Potential Partners at China Focus and the 37th Annual J.P. Morgan Healthcare Conferences in San Francisco
finance.yahoo.com - December 31 at 10:19 AM
Onconova Therapeutics Inc.Onconova Therapeutics Inc.
www.barrons.com - December 24 at 3:52 PM
Onconova Welcomes Avi Oler, JD, MBA, as Vice President, Corporate Development and General CounselOnconova Welcomes Avi Oler, JD, MBA, as Vice President, Corporate Development and General Counsel
finance.yahoo.com - December 10 at 10:44 AM
Onconova: Strong HR-MDS Data At ASH Makes It Highly Interesting NowOnconova: Strong HR-MDS Data At ASH Makes It Highly Interesting Now
seekingalpha.com - December 7 at 9:56 AM
Onconova Therapeutics (ONTX) Reports Phase 2 Trial of Oral Rigosertib in Combination with Azacitidine (Vidaza) in Myelodysplastic SyndromesOnconova Therapeutics (ONTX) Reports Phase 2 Trial of Oral Rigosertib in Combination with Azacitidine (Vidaza) in Myelodysplastic Syndromes
www.streetinsider.com - December 4 at 10:22 AM
Onconova highlights results from Phase 2 trial of oral rigosertib in combination with azacitidine in MDSOnconova highlights results from Phase 2 trial of oral rigosertib in combination with azacitidine in MDS
seekingalpha.com - December 3 at 10:33 AM
Onconova Highlights Results from Phase 2 Trial of Oral Rigosertib In Combination with Azacitidine (Vidaza®) in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual MeetingOnconova Highlights Results from Phase 2 Trial of Oral Rigosertib In Combination with Azacitidine (Vidaza®) in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting
finance.yahoo.com - December 3 at 10:33 AM
Onconova Therapeutics: The Many Strengths Of INSPIREOnconova Therapeutics: The Many Strengths Of INSPIRE
seekingalpha.com - November 27 at 3:49 PM
Edited Transcript of ONTX earnings conference call or presentation 13-Nov-18 2:00pm GMTEdited Transcript of ONTX earnings conference call or presentation 13-Nov-18 2:00pm GMT
finance.yahoo.com - November 14 at 9:41 AM
Onconovas (ONTX) CEO Dr. Ramesh Kumar on Q3 2018 Results - Earnings Call TranscriptOnconova's (ONTX) CEO Dr. Ramesh Kumar on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 13 at 4:01 PM
Onconova Therapeutics Announces Business Highlights and Financial Results for Third Quarter 2018Onconova Therapeutics Announces Business Highlights and Financial Results for Third Quarter 2018
finance.yahoo.com - November 13 at 9:44 AM
Onconova Therapeutics (ONTX) May Report Negative Earnings: Know the Trend Ahead of Next Weeks ReleaseOnconova Therapeutics (ONTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
www.msn.com - November 6 at 3:55 PM
Onconova Therapeutics (ONTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseOnconova Therapeutics (ONTX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - November 6 at 3:55 PM
Onconova Therapeutics (ONTX) Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic ...Onconova Therapeutics (ONTX) Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic ...
www.streetinsider.com - November 5 at 3:57 PM
Onconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & ExpositionOnconova Announces Four Presentations from Rigosertib Clinical Trials in Myelodysplastic Syndromes (MDS) at the 2018 ASH Annual Meeting & Exposition
finance.yahoo.com - November 5 at 3:57 PM
Will Onconova Therapeutics (ONTX) Report Negative Earnings Next Week? What You Should KnowWill Onconova Therapeutics (ONTX) Report Negative Earnings Next Week? What You Should Know
www.zacks.com - November 2 at 10:55 AM
This page was last updated on 7/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel